Rothschild & Co Redburn analyst Simon Baker upgraded Novo Nordisk (NVO) to Buy from Neutral with a DKK 440 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk announced results from INFORM survey on semaglutide
- Novo Nordisk Stock (NVO) Rises After Triple-Dose Trial Hits 19% Weight Loss
- Novo looks to broaden options, stay competitive in weight-loss space, FT says
- Mixed options sentiment in Novo Nordisk with shares up 1.15%
- Microsoft, OpenAI sign MOU for next phase of partnership: Morning Buzz